3 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Intestinal Polyposis: new trials by email Literature Review of Intestinal Polyposis trials Research Report on Intestinal Polyposis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) Eflornithine, Eflornithine Placebo, Sulindac 150 MG - Familial Adenomatous Polyposis | Phase 3 | Completed | Cancer Prevention Pharmaceuticals, Inc. | 171 | 2013-10-01 | 2021-06-08 |
| Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis Celecoxib, Ursodeoxycholic acid, Placebo - Familial Adenomatous Polyposis, Duodenal Neoplasms | Phase 2 / Phase 3 | Completed | Radboud University Medical Center | 37 | 2009-05-01 | 2013-05-16 |
| Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA Eicosapentanoic Acid (EPA), Endoscopy, Biopsies taken - Familial Adenomatous Polyposis Coli, FAP | Phase 2 / Phase 3 | Completed | S.L.A. Pharma AG | 58 | 2006-11-01 | 2014-08-22 |
Adenomatous Polyposis Coli (3) · Polyps (2) · Adenoma (1) · Adenomatous Polyps (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Duodenal Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genetic Diseases, Inborn (1) · Hyperplasia (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplastic Syndromes, Hereditary (1)
Colonic Diseases (3) · Colorectal Neoplasms (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Glandular and Epithelial (3) · Adenoma (2) · Adenomatous Polyps (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Genetic Diseases, Inborn (2)
Celecoxib (1) · Eflornithine (1) · Eicosapentaenoic Acid (1) · Endoscopy (1) · Sulindac (1) · Ursodeoxycholic Acid (1)
Cancer Prevention Pharmaceuticals, Inc. (1) · Radboud University Medical Center (1) · S.L.A. Pharma AG (1)
Netherlands (2) · United Kingdom (2) · Belgium (1) · Canada (1) · Germany (1) · Spain (1) · United States (1)
Bjorn WH van Heumen, MD (1) · Carol Burke, M.D. (1) · Ellen Kampman, Ph D (1) · Fokko M Nagengast, MD, Ph D (1) · James Church, M.D. (1) · Nicholas J West, MB BS FRCS (1) · Wilbert HM Peters, Ph D (1)
PMID 20348368, PMID 23919274, PMID 24245549, PMID 32905675, PMID 34261858